PROSPECTIVE EVALUATION OF HOT FLASHES DURING TREATMENT WITH PARENTERAL ESTROGEN OR COMPLETE ANDROGEN ABLATION FOR METASTATIC CARCINOMA OF THE PROSTATE
- 1 August 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 166 (2) , 517-520
- https://doi.org/10.1016/s0022-5347(05)65973-3
Abstract
Conclusions Endocrine treatment with polyestradiol phosphate induced fewer and less distressing hot flashes than complete androgen ablation. Flashes also disappeared to a greater extent during polyestradiol phosphate than during androgen ablation. The data in this study enable us to provide thorough individual information to patients on the risk and grade of expected distress and duration of hot flashes during polyestradiol phosphate or complete androgen ablation treatment.Keywords
This publication has 19 references indexed in Scilit:
- Prostate carcinoma trends in three counties in Sweden 1987-1996Cancer, 2000
- Comparison of goserelin and leuprolide in combined androgen blockade therapyUrology, 1998
- Prevalence and Duration of Hot Flushes After Surgical or Medical Castration in Men with Prostatic CarcinomaJournal of Urology, 1994
- Laboratory and Ambulatory Monitoring of Menopausal Hot FlashesPsychophysiology, 1989
- Phase III studies to compare goserelin (zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinomaUrology, 1989
- Orchiectomy versus Long‐acting D‐Trp‐6‐LHRH in Advanced Prostatic CancerBritish Journal of Urology, 1987
- Pathophysiology of Hot FlushesObstetrical & Gynecological Survey, 1985
- Measurement of skin blood‐flow and water evaporation as a means of objectively assessing hot flushes after orchidectomy in patients with prostatic cancerThe Prostate, 1985
- Androgen Suppression by a Gonadotropin Releasing Hormone Analogue in Patients with Metastatic Carcinoma of the ProstateJournal of Urology, 1984
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941